<DOC>
	<DOC>NCT02270658</DOC>
	<brief_summary>MORPHEOS is a multicenter, randomized, unblinded study, for patients diagnosed with uncontrolled hypertension and at least one antihypertensive medication. Those patients with significant sleep apnea wil be randomized to CPAP or nasal strips for 6 months.</brief_summary>
	<brief_title>Morbidity in Patients With Hypertension and Obstructive Sleep Apnea</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea, Obstructive</mesh_term>
	<criteria>Systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥ 90 mm Hg Current treatment with at least 1 antihypertensive drug Age &lt;18 and ≥65 years BMI ≥ 40 kg/m2 Heart failure, EF &lt; 45%, acute myocardial infarction, stroke, significant valvular dysfunction Chronic renal failure (serum creatinine &gt; 2 mg/dL) Use of cocaine, amphetamines, alcohol, illicit drugs Use of sympathomimetics (decongestants, appetite suppressants) Use of oral contraceptives and chronic use of NSAIDs Pregnancy Secondary causes of hypertension (other than sleep apnea)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>continuous positive airway pressure</keyword>
	<keyword>hypertension</keyword>
	<keyword>sleep apnea</keyword>
</DOC>